Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma platelet aggregating factor and platelet aggregation studies in pre-eclampsia

S Ahlawat1, H P Pati, N Bhatla

  • 1Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.

Acta Obstetricia Et Gynecologica Scandinavica
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative liver transcriptomics of Kadaknath and Aseel chickens reveals molecular basis of their unique nutritional and metabolic traits.

British poultry science·2026
Same author

Exploring Medical Students' Level of Empathy and its Correlation with Prosocial Behaviour in Jharkhand, India.

Kathmandu University medical journal (KUMJ)·2026
Same author

Unveiling conserved and breed-specific RNA expression signatures underlying hepatic homoeostasis across genetically diverse chicken breeds.

British poultry science·2026
Same author

Radiometer calibration using machine learning.

Scientific reports·2025
Same author

Development and validation of a high-density SNP chip tailored for genomic analysis in Indian backyard chickens.

British poultry science·2025
Same author

Receiver design for the REACH global 21-cm signal experiment.

Experimental astronomy·2025

Plasma platelet aggregation factor (PAF) plays a role in pre-eclampsia, affecting platelet activation. Studies show abnormal platelet aggregation and PAF presence in pre-eclamptic patients.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Pathophysiology

Background:

  • Plasma platelet aggregation factor (PAF) is linked to thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS).
  • A similar mechanism involving platelet activation may contribute to pre-eclampsia pathogenesis.

Purpose of the Study:

  • To investigate the role of platelet aggregation and PAF in pre-eclampsia.
  • To compare platelet function in pre-eclamptic patients versus normal pregnant controls.

Main Methods:

  • Coagulation profiles and in vitro platelet aggregation assays were performed.
  • PAF was detected by spontaneous aggregation of normal platelets with patient plasma.
  • Statistical analysis included Wilcoxon's rank sum test and Kruskal-Wallis ANOVA.

Related Experiment Videos

Main Results:

  • Abnormal in vitro platelet aggregation was observed in 77.2% of pre-eclamptic patients.
  • PAF was demonstrable in 45.5% of pre-eclamptic patients.
  • Platelet aggregation studies revealed both hyperaggregable and hypoaggregable platelets.

Conclusions:

  • PAF presence in pre-eclampsia suggests its involvement in platelet activation pathways.
  • Platelet dysfunction, characterized by altered aggregation states, is present in pre-eclampsia.